09:47 AM EDT, 08/14/2024 (MT Newswires) -- ADMA Biologics ( ADMA ) said Wednesday that it has repaid $30 million from its original $72.5 million revolving credit facility with Ares Capital, reducing its total gross debt to $105 million.

The biopharmaceutical company said it funded the partial paydown utilizing its cash on hand.

The company said the total gross debt includes a current $62.5 million term loan and $42.5 million now outstanding under the firm's revolving credit facility.

Price: 17.49, Change: +0.22, Percent Change: +1.27